Direkt zum Inhalt
Merck

Salicylic acid: an old dog, new tricks, and staphylococcal disease.

The Journal of clinical investigation (2003-07-17)
Mathias Herrmann
ZUSAMMENFASSUNG

Aspirin has been shown to cause a reduction in the virulence of Staphylococcus aureus-associated endocarditis. A new study reveals that salicylic acid, the major metabolite of aspirin, acts at the level of transcription to downregulate the production of fibrinogen, fibronectin, and alpha-hemolysin - virulence factors necessary for bacterial replication in host tissues and, now, potential therapeutic targets.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Salicylsäure, ACS reagent, ≥99.0%
Sigma-Aldrich
Salicylsäure, ≥99%, FG
Sigma-Aldrich
Salicylsäure, BioXtra, ≥99.0%
USP
Salicylsäure, United States Pharmacopeia (USP) Reference Standard
Supelco
Salicylsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Salicylsäure, suitable for plant cell culture
Supelco
Salicylsäure, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Salicylsäure, puriss. p.a., ≥99.0% (T)
Sigma-Aldrich
Salicylsäure, meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (calc. to the dried substance)
Sigma-Aldrich
Salicylsäure, ReagentPlus®, ≥99%
Salicylsäure, European Pharmacopoeia (EP) Reference Standard
Supelco
Salicylsäure, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland